Skip to main content

Table 2 Chlamydia management and control activities in study countries

From: Provision of chlamydia testing, and training of primary health care staff about chlamydia testing, across four European countries

 

England

Estonia

France

Sweden

Written guidelines or recommendations about chlamydia diagnosis and case management

UK National Guideline for the Management of Genital Tract Infection with Chlamydia trachomatis (2006)

Estonian Union against Sexually Transmitted Infections (EUSTI), 2011

2010: Health authority recommendations on laboratory diagnostic procedure only

The Board of County Medical Officers 2010

 

British Association for Sexual Health and HIV (BASHH), 2006

   
 

National Chlamydia Screening Programme Core Guidance 6th Edition 2012

   

Guidelines recommend testing for asymptomatic people

Yes

Yes

Yes

Yes

   

Since 2003: recommendations for screening at- risk women aged 15–25 [32]

 

Repeat test recommended for patients with a positive chlamydia test

Repeat test of positives 3 months after diagnosis

Repeat test of positives 3 months after diagnosis

No

Test for cure

Additional testing for other STIs or HIV recommended for those with positive chlamydia test

Yes

Yes

Yes

Yes

 

Including HIV

Including HIV

  

Partner notification recommended

Yes (patient and provider referral)

Yes (patient referral)

Yes (patient referral)

Yes (patient and provider referral)

Written guidelines or recommendations about chlamydia diagnosis and case management specifically for GPs

Yes, contained within National Chlamydia Screening Programme Core Guidance 6th Edition 2012 and BASHH 2006

No

No

Yes, Recommendations from the Board of County Medical officers, 2010

 

Royal College of General Practitioners 2013 Sexually Transmitted Infections in primary care guidelines

   

National chlamydia screening program

Yes

No

No

No

National surveillance data for chlamydia routinely reported

Yes

Yes

No (Not routinely, but intermittently)

Yes

Chlamydia cases reported by

Laboratories

Settings in which they are diagnosed (= physicians)

Surveillance network of volunteer (not compulsory, not reimbursed) laboratories that report detection rates of chlamydia (ReNaChla)

Settings in which they are diagnosed (= physicians)

Settings providing chlamydia testing (GUM = genitourinary medicine clinic; STI = sexually transmitted infections clinics; GYN = gynecology clinics)

GUM, sexual and reproductive health services, GPs, pharmacies, termination of pregnancy providers, internet based services, other (including targeted youth services)

Youth Health Centres; GYN; STI; internet based self-sampling;

GP; STI, GYN; Family planning clinic; Internal medicine specialist

GP; STI, GYN; ER; internet based self-sampling; Family planning clinic; Youth Health Centres

Main site for chlamydia testing

Men/women - GUM, primary care settings including GP

Women - GYN;

Youth - free and

Women: Family planning

  

Men – STI clinic

anonymous family

or GP Men: STI clinic or GP

  

Youth – Youth health centres

planning clinics

Youth - Youth surgeries

Breakdown of chlamydia cases by setting for diagnosis or treatment (top 3)

STI/GUM 29%

STI 20%

Presumed to originate

STI 25%

 

GP 18%

GP 6%

mainly from Youth Health

GP 10%

 

Family planning 15%

Youth Health Centres 30%

Centres and STI, Family

Youth Health Centres 40%

 

Other 33%

GYN 30%

planning clinics